Gamified Incentive Spirometry for Chest Trauma
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to assist individuals with breathing difficulties after chest injuries using a gamified breathing system called the OmniFlow Breathing Therapy BioFeedback System. The goal is to determine if gamifying breathing exercises increases patient participation. It targets adults in the Trauma Intensive Care Unit (TICU) with rib or sternum fractures who can begin the exercises within 48 hours of admission. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance recovery for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the OmniFlow Breathing Therapy BioFeedback System is safe for use in patients with chest trauma?
Research has shown that the OmniFlow Breathing Therapy BioFeedback System is safe for individuals with breathing problems. The FDA has approved this system, indicating it meets safety standards for medical use. In past studies, patients used this system without major safety issues. It assists with breathing exercises by gamifying them, making it easier and more enjoyable to maintain the exercises.
Since the OmniFlow system is already approved for use, any risks are likely minimal and well understood. This makes it a promising option for those seeking to improve their breathing through engaging, game-like exercises.12345Why are researchers excited about this trial?
The OmniFlow Breathing Therapy BioFeedback System is unique because it combines FDA-approved healthcare with gaming technology to make breathing exercises more engaging for patients with chest trauma. Traditional treatments often involve standard incentive spirometry, which can be repetitive and lacks interactive features. This system stands out by offering biofeedback, which gives real-time responses to patients, making it easier for them to track their progress and stay motivated. Researchers are excited about its potential to improve patient adherence to pulmonary rehab, possibly leading to better outcomes and quicker recovery times.
What evidence suggests that the OmniFlow Breathing Therapy BioFeedback System is effective for chest trauma?
Research shows that the OmniFlow Breathing Therapy BioFeedback System, used by participants in this trial, can improve lung function. Studies have found that it greatly increases adherence to breathing exercises, especially in patients with chest injuries. By turning breathing exercises into a game, this system keeps patients engaged. Early results indicate that it strengthens breathing muscles and enhances overall lung health compared to traditional methods. Overall, the OmniFlow system offers a promising approach to making respiratory therapy more interactive and enjoyable.12456
Who Is on the Research Team?
Aarti Sarwal, MD
Principal Investigator
Wake Forest University Health Sciences
Are You a Good Fit for This Trial?
This trial is for adults (18+) in the Trauma Intensive Care Unit with rib fractures or similar chest injuries. They must be able to give consent and start gamified breathing therapy within 48 hours of admission.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the OmniFlow Breathing Therapy BioFeedback System for pulmonary rehabilitation
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- OmniFlow Breathing Therapy BioFeeback System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor